|
 |
|
| |
Message From The Company |
|
|
|
A Message from Rosetta Genomics Ltd.
Rosetta Genomics is the first commercial entity to focus on the emerging field of microRNA. The company is a leader in medical research and product development based on microRNA. Using our own proprietary bioinformatic technologies, researchers at Rosetta have identified more than 50% of the human microRNAs of which we are aware. From this unparalleled intellectual property platform, Rosetta is actively advancing multiple internal programs in microRNA diagnostic and therapeutic product development. We are also establishing licensing agreements and collaborative relationships with leading companies and research institutions working to develop microRNA-based products. |
|
| Our Most Recent Webcast |
 |
| SYMBOL |
EVENT TITLE |
LISTEN |
DATE |
TIME (ET) |
| ROSGD |
Rosetta Genomics Business Update Call |
 |
10-Apr-13 |
10:00 AM |
|
| Our Most Recent Annual Report |
|
| SYMBOL |
REPORT TITLE |
DATE |
FORMAT |
| ROSGD |
2010 20-F |
31-Mar-2011 |
 |
|
|
